SYS6020 CAR T-cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SYS6020 CAR T-cells, covering 2025-08-06 to 2025-08-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis [Phase 1]